BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock. In connection with the offering, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback